| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rett Syndrome | 80 | 2026 | 226 | 18.400 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 87 | 2026 | 281 | 18.260 |
Why?
|
| Spinocerebellar Ataxias | 63 | 2024 | 259 | 11.550 |
Why?
|
| Nerve Tissue Proteins | 110 | 2022 | 1122 | 8.770 |
Why?
|
| Neurons | 63 | 2026 | 1990 | 7.780 |
Why?
|
| Ataxin-1 | 88 | 2024 | 161 | 6.670 |
Why?
|
| Cerebellum | 44 | 2023 | 460 | 5.910 |
Why?
|
| Nuclear Proteins | 81 | 2022 | 1226 | 5.660 |
Why?
|
| Mice | 228 | 2026 | 18488 | 4.660 |
Why?
|
| Disease Models, Animal | 89 | 2026 | 4696 | 4.630 |
Why?
|
| Repressor Proteins | 35 | 2019 | 777 | 4.440 |
Why?
|
| Animals | 295 | 2026 | 34375 | 4.290 |
Why?
|
| Spinocerebellar Degenerations | 40 | 2005 | 62 | 3.380 |
Why?
|
| Peptides | 42 | 2025 | 835 | 3.330 |
Why?
|
| DNA-Binding Proteins | 36 | 2021 | 1958 | 3.210 |
Why?
|
| Mice, Transgenic | 76 | 2025 | 2363 | 3.150 |
Why?
|
| Nervous System Diseases | 12 | 2024 | 403 | 3.110 |
Why?
|
| Mutation | 80 | 2026 | 6177 | 3.010 |
Why?
|
| Oligonucleotides, Antisense | 5 | 2025 | 73 | 2.960 |
Why?
|
| Gene Expression Regulation | 28 | 2025 | 2357 | 2.800 |
Why?
|
| Chromosomal Proteins, Non-Histone | 19 | 2004 | 205 | 2.750 |
Why?
|
| alpha-Synuclein | 9 | 2025 | 140 | 2.680 |
Why?
|
| X Chromosome | 35 | 2004 | 331 | 2.660 |
Why?
|
| Brain | 52 | 2025 | 3239 | 2.630 |
Why?
|
| Parkinson Disease | 11 | 2025 | 725 | 2.520 |
Why?
|
| Transcription, Genetic | 20 | 2025 | 1397 | 2.450 |
Why?
|
| Purkinje Cells | 43 | 2023 | 170 | 2.410 |
Why?
|
| Neurodegenerative Diseases | 19 | 2025 | 288 | 2.320 |
Why?
|
| Mice, Knockout | 58 | 2024 | 3864 | 2.300 |
Why?
|
| tau Proteins | 5 | 2024 | 258 | 2.290 |
Why?
|
| Ataxins | 69 | 2015 | 111 | 2.210 |
Why?
|
| Chromatin | 9 | 2024 | 491 | 2.180 |
Why?
|
| Nerve Degeneration | 9 | 2018 | 129 | 2.150 |
Why?
|
| Trinucleotide Repeats | 22 | 2019 | 106 | 2.120 |
Why?
|
| Gene Expression Regulation, Developmental | 28 | 2024 | 1005 | 2.070 |
Why?
|
| Tauopathies | 3 | 2024 | 75 | 2.020 |
Why?
|
| Trinucleotide Repeat Expansion | 13 | 2025 | 120 | 1.910 |
Why?
|
| Gene Deletion | 17 | 2021 | 773 | 1.830 |
Why?
|
| Rhombencephalon | 5 | 2024 | 68 | 1.800 |
Why?
|
| Autistic Disorder | 15 | 2026 | 396 | 1.780 |
Why?
|
| Behavior, Animal | 24 | 2021 | 510 | 1.780 |
Why?
|
| Transcription Factors | 27 | 2022 | 2437 | 1.770 |
Why?
|
| Phosphorylation | 27 | 2025 | 1571 | 1.670 |
Why?
|
| Mice, Inbred C57BL | 43 | 2025 | 4769 | 1.660 |
Why?
|
| Humans | 294 | 2026 | 131680 | 1.620 |
Why?
|
| Neurogenesis | 8 | 2024 | 224 | 1.580 |
Why?
|
| Motor Activity | 12 | 2021 | 508 | 1.570 |
Why?
|
| Cell Nucleus | 17 | 2018 | 567 | 1.550 |
Why?
|
| Respiratory Center | 3 | 2019 | 9 | 1.540 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2026 | 3413 | 1.530 |
Why?
|
| Alleles | 28 | 2024 | 1708 | 1.450 |
Why?
|
| Phenotype | 54 | 2024 | 4516 | 1.450 |
Why?
|
| Gene Knock-In Techniques | 8 | 2025 | 122 | 1.450 |
Why?
|
| Haploinsufficiency | 8 | 2025 | 264 | 1.430 |
Why?
|
| Motor Neurons | 4 | 2022 | 130 | 1.400 |
Why?
|
| Cell Lineage | 10 | 2024 | 349 | 1.350 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 4 | 2021 | 37 | 1.350 |
Why?
|
| RNA Splicing | 4 | 2018 | 234 | 1.350 |
Why?
|
| Neuronal Plasticity | 11 | 2025 | 289 | 1.340 |
Why?
|
| Protein Stability | 8 | 2021 | 166 | 1.340 |
Why?
|
| Cell Differentiation | 19 | 2024 | 1947 | 1.310 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 26 | 2011 | 351 | 1.300 |
Why?
|
| Chromosomes, Human, Pair 6 | 28 | 1995 | 139 | 1.280 |
Why?
|
| RNA-Binding Proteins | 7 | 2018 | 550 | 1.240 |
Why?
|
| Brain Stem | 5 | 2021 | 112 | 1.230 |
Why?
|
| Gene Expression | 18 | 2016 | 1502 | 1.220 |
Why?
|
| Hippocampus | 11 | 2024 | 806 | 1.220 |
Why?
|
| Genetic Linkage | 35 | 2005 | 472 | 1.210 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2012 | 81 | 1.200 |
Why?
|
| Deep Brain Stimulation | 5 | 2018 | 456 | 1.160 |
Why?
|
| RNA Splicing Factors | 4 | 2018 | 52 | 1.160 |
Why?
|
| Neuropeptides | 6 | 2019 | 111 | 1.160 |
Why?
|
| Awards and Prizes | 3 | 2015 | 63 | 1.160 |
Why?
|
| Protein Structure, Tertiary | 12 | 2020 | 723 | 1.140 |
Why?
|
| RNA Interference | 4 | 2019 | 496 | 1.140 |
Why?
|
| Transcriptome | 8 | 2024 | 1163 | 1.140 |
Why?
|
| Male | 128 | 2026 | 65267 | 1.140 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 2023 | 16 | 1.130 |
Why?
|
| GABAergic Neurons | 2 | 2020 | 66 | 1.090 |
Why?
|
| Female | 145 | 2026 | 71186 | 1.080 |
Why?
|
| Autism Spectrum Disorder | 6 | 2020 | 442 | 1.060 |
Why?
|
| Protein Binding | 25 | 2025 | 1712 | 1.050 |
Why?
|
| Molecular Sequence Data | 57 | 2016 | 3616 | 1.040 |
Why?
|
| Alternative Splicing | 7 | 2026 | 314 | 1.020 |
Why?
|
| Gene Duplication | 9 | 2024 | 364 | 1.020 |
Why?
|
| Biomedical Research | 6 | 2025 | 556 | 0.990 |
Why?
|
| Aging | 7 | 2023 | 1265 | 0.980 |
Why?
|
| Drosophila | 16 | 2025 | 795 | 0.960 |
Why?
|
| Microfilament Proteins | 5 | 2019 | 272 | 0.950 |
Why?
|
| Chromosome Mapping | 43 | 2013 | 1069 | 0.940 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2026 | 253 | 0.930 |
Why?
|
| Histones | 6 | 2024 | 518 | 0.910 |
Why?
|
| Developmental Disabilities | 7 | 2020 | 760 | 0.900 |
Why?
|
| TYK2 Kinase | 1 | 2024 | 4 | 0.890 |
Why?
|
| Intellectual Disability | 14 | 2019 | 1072 | 0.890 |
Why?
|
| Gene Expression Profiling | 15 | 2020 | 1833 | 0.890 |
Why?
|
| Synapses | 11 | 2022 | 446 | 0.880 |
Why?
|
| Cytosol | 1 | 2025 | 140 | 0.880 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2025 | 611 | 0.880 |
Why?
|
| Dosage Compensation, Genetic | 12 | 2005 | 57 | 0.850 |
Why?
|
| Base Sequence | 46 | 2018 | 2783 | 0.840 |
Why?
|
| MicroRNAs | 4 | 2020 | 894 | 0.830 |
Why?
|
| Gene Dosage | 7 | 2015 | 439 | 0.820 |
Why?
|
| Drosophila melanogaster | 9 | 2025 | 846 | 0.820 |
Why?
|
| Social Behavior | 9 | 2015 | 217 | 0.810 |
Why?
|
| Polyadenylation | 3 | 2020 | 48 | 0.810 |
Why?
|
| Amacrine Cells | 1 | 2023 | 42 | 0.800 |
Why?
|
| Memory Disorders | 7 | 2022 | 207 | 0.790 |
Why?
|
| Serine | 11 | 2021 | 163 | 0.790 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 368 | 0.790 |
Why?
|
| Fragile X Syndrome | 8 | 2014 | 148 | 0.780 |
Why?
|
| Cells, Cultured | 16 | 2021 | 2971 | 0.780 |
Why?
|
| Hypothalamus | 3 | 2009 | 205 | 0.770 |
Why?
|
| Learning | 5 | 2021 | 369 | 0.770 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 2 | 2020 | 15 | 0.760 |
Why?
|
| RNA, Messenger | 26 | 2025 | 2568 | 0.750 |
Why?
|
| Mutation, Missense | 7 | 2019 | 929 | 0.750 |
Why?
|
| Fornix, Brain | 3 | 2018 | 23 | 0.750 |
Why?
|
| Cytoplasm | 9 | 2021 | 254 | 0.740 |
Why?
|
| Mortality, Premature | 1 | 2022 | 16 | 0.740 |
Why?
|
| Microphthalmos | 9 | 2002 | 55 | 0.740 |
Why?
|
| Amino Acid Sequence | 26 | 2018 | 2564 | 0.700 |
Why?
|
| Biomedical Enhancement | 1 | 2021 | 1 | 0.690 |
Why?
|
| Huntington Disease | 8 | 2007 | 142 | 0.690 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2012 | 51 | 0.690 |
Why?
|
| Spinal Cord | 7 | 2018 | 269 | 0.690 |
Why?
|
| Retina | 4 | 2023 | 462 | 0.690 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2021 | 30 | 0.680 |
Why?
|
| Prodromal Symptoms | 1 | 2021 | 11 | 0.680 |
Why?
|
| Disease Susceptibility | 3 | 2022 | 283 | 0.680 |
Why?
|
| Nervous System | 5 | 2012 | 123 | 0.670 |
Why?
|
| Genes, Dominant | 15 | 2014 | 252 | 0.670 |
Why?
|
| Genetic Therapy | 2 | 2025 | 726 | 0.660 |
Why?
|
| 5' Untranslated Regions | 2 | 2020 | 57 | 0.660 |
Why?
|
| Mice, Mutant Strains | 8 | 2021 | 366 | 0.660 |
Why?
|
| Medulloblastoma | 2 | 2017 | 384 | 0.650 |
Why?
|
| Cell Movement | 6 | 2024 | 881 | 0.650 |
Why?
|
| Dendritic Spines | 5 | 2021 | 57 | 0.650 |
Why?
|
| Exons | 13 | 2026 | 769 | 0.650 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 2 | 2018 | 16 | 0.650 |
Why?
|
| DNA Methylation | 8 | 2026 | 1086 | 0.640 |
Why?
|
| Neurobiology | 3 | 2016 | 26 | 0.640 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 749 | 0.640 |
Why?
|
| Seizures | 5 | 2018 | 889 | 0.640 |
Why?
|
| 14-3-3 Proteins | 4 | 2021 | 57 | 0.640 |
Why?
|
| Carrier Proteins | 11 | 2020 | 1024 | 0.630 |
Why?
|
| Hair Cells, Auditory | 2 | 2017 | 66 | 0.630 |
Why?
|
| Membrane Proteins | 10 | 2020 | 1613 | 0.630 |
Why?
|
| Interneurons | 4 | 2022 | 146 | 0.620 |
Why?
|
| Homeostasis | 6 | 2018 | 713 | 0.610 |
Why?
|
| Neurosciences | 3 | 2010 | 48 | 0.610 |
Why?
|
| Signal Transduction | 13 | 2021 | 4683 | 0.600 |
Why?
|
| Cell Line | 22 | 2021 | 2605 | 0.600 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 382 | 0.600 |
Why?
|
| Molecular Chaperones | 6 | 2007 | 173 | 0.590 |
Why?
|
| Protein Kinases | 3 | 2019 | 322 | 0.590 |
Why?
|
| DNA | 29 | 2015 | 1442 | 0.590 |
Why?
|
| Disease | 2 | 2016 | 125 | 0.590 |
Why?
|
| Stem Cells | 6 | 2008 | 713 | 0.590 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 356 | 0.580 |
Why?
|
| Genes, Duplicate | 2 | 2015 | 16 | 0.580 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 106 | 0.570 |
Why?
|
| Mental Disorders | 5 | 2022 | 904 | 0.570 |
Why?
|
| HEK293 Cells | 7 | 2021 | 810 | 0.570 |
Why?
|
| Hypercapnia | 1 | 2018 | 23 | 0.570 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 156 | 0.560 |
Why?
|
| Chromosomes, Human, X | 6 | 2026 | 155 | 0.560 |
Why?
|
| p21-Activated Kinases | 1 | 2018 | 56 | 0.560 |
Why?
|
| Somatostatin | 2 | 2015 | 60 | 0.550 |
Why?
|
| Neural Inhibition | 2 | 2016 | 111 | 0.550 |
Why?
|
| Movement Disorders | 5 | 2017 | 224 | 0.550 |
Why?
|
| ras Proteins | 3 | 2021 | 146 | 0.540 |
Why?
|
| Drosophila Proteins | 9 | 2025 | 788 | 0.540 |
Why?
|
| Respiratory System | 1 | 2018 | 97 | 0.530 |
Why?
|
| Genetic Testing | 7 | 2021 | 1099 | 0.530 |
Why?
|
| Glycoproteins | 1 | 2019 | 344 | 0.530 |
Why?
|
| Substance P | 1 | 2017 | 32 | 0.520 |
Why?
|
| Pedigree | 29 | 2018 | 1710 | 0.520 |
Why?
|
| Cerebral Cortex | 4 | 2021 | 468 | 0.520 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 875 | 0.510 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 91 | 0.500 |
Why?
|
| Hypoxia | 1 | 2018 | 245 | 0.500 |
Why?
|
| Sodium Channels | 1 | 2017 | 99 | 0.500 |
Why?
|
| Electrophysiology | 8 | 2021 | 252 | 0.490 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 139 | 0.490 |
Why?
|
| Memory | 5 | 2015 | 358 | 0.490 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2014 | 21 | 0.490 |
Why?
|
| Proprioception | 2 | 2009 | 17 | 0.490 |
Why?
|
| Polymorphism, Genetic | 16 | 2000 | 794 | 0.490 |
Why?
|
| Genetic Markers | 18 | 1995 | 605 | 0.480 |
Why?
|
| Ataxia | 9 | 2018 | 169 | 0.480 |
Why?
|
| Sodium | 2 | 2017 | 281 | 0.480 |
Why?
|
| Frontotemporal Dementia | 1 | 2016 | 67 | 0.470 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 242 | 0.470 |
Why?
|
| alpha Karyopherins | 1 | 2015 | 8 | 0.470 |
Why?
|
| Parvalbumins | 1 | 2015 | 36 | 0.470 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 71 | 0.470 |
Why?
|
| Polymerase Chain Reaction | 22 | 2018 | 1489 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2013 | 189 | 0.470 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 3673 | 0.460 |
Why?
|
| Immunization, Passive | 1 | 2015 | 124 | 0.460 |
Why?
|
| Skin Abnormalities | 6 | 2002 | 35 | 0.460 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2015 | 115 | 0.460 |
Why?
|
| Hearing Loss | 1 | 2017 | 210 | 0.450 |
Why?
|
| Integrases | 3 | 2023 | 158 | 0.450 |
Why?
|
| Mutant Proteins | 3 | 2019 | 113 | 0.440 |
Why?
|
| Pyramidal Cells | 3 | 2022 | 147 | 0.440 |
Why?
|
| Periodicity | 2 | 2017 | 49 | 0.440 |
Why?
|
| DNA Copy Number Variations | 5 | 2024 | 1023 | 0.440 |
Why?
|
| Carcinogenesis | 1 | 2017 | 357 | 0.440 |
Why?
|
| Genotype | 17 | 2020 | 2655 | 0.440 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 177 | 0.440 |
Why?
|
| Polymorphism, Restriction Fragment Length | 11 | 1992 | 138 | 0.430 |
Why?
|
| Synaptic Transmission | 5 | 2020 | 329 | 0.430 |
Why?
|
| Long-Term Potentiation | 6 | 2015 | 105 | 0.420 |
Why?
|
| Immunohistochemistry | 16 | 2024 | 1610 | 0.420 |
Why?
|
| Down-Regulation | 7 | 2013 | 659 | 0.420 |
Why?
|
| Subthalamic Nucleus | 1 | 2014 | 52 | 0.420 |
Why?
|
| Anxiety | 4 | 2020 | 1028 | 0.410 |
Why?
|
| Calcium | 3 | 2017 | 1041 | 0.400 |
Why?
|
| Glutamine | 7 | 2008 | 202 | 0.390 |
Why?
|
| Inclusion Bodies | 8 | 2003 | 39 | 0.390 |
Why?
|
| Homeodomain Proteins | 10 | 2014 | 568 | 0.390 |
Why?
|
| Conserved Sequence | 6 | 2021 | 282 | 0.390 |
Why?
|
| Genes, Reporter | 9 | 2020 | 350 | 0.390 |
Why?
|
| Syndrome | 17 | 2018 | 1168 | 0.390 |
Why?
|
| DNA Mutational Analysis | 13 | 2011 | 803 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2019 | 57 | 0.380 |
Why?
|
| Genomic Instability | 2 | 2005 | 250 | 0.380 |
Why?
|
| Intranuclear Inclusion Bodies | 3 | 2018 | 11 | 0.380 |
Why?
|
| Transgenes | 5 | 2013 | 323 | 0.370 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 24 | 0.370 |
Why?
|
| Intestines | 2 | 2007 | 592 | 0.370 |
Why?
|
| Calcium Channels, N-Type | 6 | 2010 | 47 | 0.370 |
Why?
|
| Brain Diseases | 5 | 2020 | 305 | 0.360 |
Why?
|
| Threonine | 1 | 2012 | 62 | 0.360 |
Why?
|
| Age of Onset | 8 | 2018 | 632 | 0.360 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 2 | 2013 | 11 | 0.360 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 34 | 0.360 |
Why?
|
| Genome, Human | 6 | 2026 | 1332 | 0.360 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 2011 | 2 | 0.350 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2021 | 102 | 0.350 |
Why?
|
| Corticosterone | 2 | 2012 | 53 | 0.340 |
Why?
|
| Child | 35 | 2025 | 26299 | 0.340 |
Why?
|
| Computational Biology | 6 | 2020 | 872 | 0.340 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 138 | 0.340 |
Why?
|
| Gene Targeting | 8 | 2020 | 171 | 0.330 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2010 | 13 | 0.330 |
Why?
|
| History, 20th Century | 4 | 2019 | 366 | 0.330 |
Why?
|
| GTPase-Activating Proteins | 3 | 2001 | 86 | 0.330 |
Why?
|
| Calcium Channels | 6 | 2010 | 148 | 0.320 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 231 | 0.320 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 588 | 0.320 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 224 | 0.320 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 365 | 0.320 |
Why?
|
| Cloning, Molecular | 18 | 2005 | 786 | 0.320 |
Why?
|
| Spiral Ganglion | 1 | 2009 | 10 | 0.310 |
Why?
|
| Morphogenesis | 2 | 2008 | 199 | 0.310 |
Why?
|
| Exercise Therapy | 1 | 2011 | 175 | 0.310 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2018 | 233 | 0.310 |
Why?
|
| Codon, Nonsense | 2 | 2020 | 141 | 0.310 |
Why?
|
| Arousal | 1 | 2009 | 77 | 0.310 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 179 | 0.310 |
Why?
|
| Merkel Cells | 1 | 2009 | 5 | 0.310 |
Why?
|
| Skin Physiological Phenomena | 1 | 2009 | 16 | 0.310 |
Why?
|
| DNA Repeat Expansion | 3 | 2007 | 73 | 0.300 |
Why?
|
| Hearing | 1 | 2009 | 61 | 0.300 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 80 | 0.300 |
Why?
|
| Genome | 3 | 2018 | 473 | 0.300 |
Why?
|
| Neurology | 2 | 2013 | 121 | 0.300 |
Why?
|
| Hyperkinesis | 2 | 2013 | 27 | 0.300 |
Why?
|
| Mice, Neurologic Mutants | 5 | 2007 | 75 | 0.300 |
Why?
|
| Central Nervous System | 2 | 2002 | 286 | 0.300 |
Why?
|
| Protein Methyltransferases | 3 | 2007 | 9 | 0.300 |
Why?
|
| Touch | 1 | 2009 | 39 | 0.300 |
Why?
|
| Child, Preschool | 28 | 2025 | 15057 | 0.300 |
Why?
|
| Point Mutation | 4 | 2014 | 339 | 0.290 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1788 | 0.290 |
Why?
|
| Protein Folding | 6 | 2006 | 215 | 0.290 |
Why?
|
| Rotarod Performance Test | 6 | 2021 | 15 | 0.290 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 203 | 0.290 |
Why?
|
| Respiration | 5 | 2018 | 120 | 0.290 |
Why?
|
| Binding Sites | 8 | 2021 | 1202 | 0.290 |
Why?
|
| Chromosomes, Artificial, Yeast | 5 | 1996 | 42 | 0.280 |
Why?
|
| Blotting, Western | 8 | 2015 | 1018 | 0.280 |
Why?
|
| Appetite Regulation | 1 | 2008 | 44 | 0.280 |
Why?
|
| Animals, Newborn | 7 | 2021 | 1024 | 0.280 |
Why?
|
| Physicians | 1 | 2015 | 634 | 0.280 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2008 | 7 | 0.280 |
Why?
|
| Heat-Shock Proteins | 3 | 2005 | 178 | 0.280 |
Why?
|
| Somatomedins | 1 | 2008 | 33 | 0.280 |
Why?
|
| CpG Islands | 3 | 2014 | 338 | 0.280 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2016 | 102 | 0.280 |
Why?
|
| Electroencephalography | 10 | 2025 | 869 | 0.280 |
Why?
|
| Caspases | 2 | 2006 | 157 | 0.270 |
Why?
|
| Models, Biological | 9 | 2022 | 1392 | 0.270 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2007 | 72 | 0.270 |
Why?
|
| Ataxin-7 | 7 | 2011 | 15 | 0.270 |
Why?
|
| Biomarkers | 7 | 2022 | 3405 | 0.270 |
Why?
|
| Hypothalamic Diseases | 1 | 2008 | 40 | 0.270 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 14 | 0.270 |
Why?
|
| Cell Division | 4 | 2023 | 731 | 0.270 |
Why?
|
| Hybrid Cells | 20 | 1995 | 78 | 0.270 |
Why?
|
| Fluorescent Antibody Technique | 7 | 2016 | 420 | 0.270 |
Why?
|
| Cell Cycle | 3 | 2023 | 598 | 0.260 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 21 | 0.260 |
Why?
|
| Two-Hybrid System Techniques | 7 | 2011 | 61 | 0.260 |
Why?
|
| COUP Transcription Factor I | 2 | 2020 | 54 | 0.260 |
Why?
|
| HLA Antigens | 5 | 1992 | 229 | 0.260 |
Why?
|
| Nervous System Malformations | 2 | 2006 | 133 | 0.260 |
Why?
|
| Organ Specificity | 10 | 2013 | 400 | 0.260 |
Why?
|
| Time Factors | 7 | 2021 | 6279 | 0.260 |
Why?
|
| Proteins | 4 | 2005 | 1027 | 0.260 |
Why?
|
| Acetylation | 2 | 2024 | 181 | 0.260 |
Why?
|
| Antimanic Agents | 1 | 2007 | 35 | 0.260 |
Why?
|
| Lyases | 4 | 2002 | 12 | 0.250 |
Why?
|
| Glutamic Acid | 4 | 2009 | 209 | 0.250 |
Why?
|
| Protein Isoforms | 3 | 2026 | 421 | 0.250 |
Why?
|
| Methylation | 6 | 2019 | 200 | 0.250 |
Why?
|
| Abnormalities, Multiple | 5 | 2014 | 974 | 0.250 |
Why?
|
| Animals, Genetically Modified | 7 | 2013 | 331 | 0.250 |
Why?
|
| In Vitro Techniques | 7 | 2009 | 824 | 0.250 |
Why?
|
| Cerebellar Neoplasms | 1 | 2009 | 320 | 0.250 |
Why?
|
| Fear | 5 | 2016 | 198 | 0.240 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 315 | 0.240 |
Why?
|
| Apoptosis | 6 | 2016 | 1861 | 0.240 |
Why?
|
| Green Fluorescent Proteins | 6 | 2013 | 382 | 0.240 |
Why?
|
| Genes | 5 | 1999 | 308 | 0.240 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 310 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 1236 | 0.240 |
Why?
|
| Oligodeoxyribonucleotides | 7 | 1995 | 121 | 0.240 |
Why?
|
| Phosphoproteins | 2 | 2007 | 435 | 0.230 |
Why?
|
| Transfection | 9 | 2008 | 960 | 0.230 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 2990 | 0.230 |
Why?
|
| RNA Polymerase II | 1 | 2025 | 90 | 0.230 |
Why?
|
| Multiprotein Complexes | 2 | 2022 | 194 | 0.230 |
Why?
|
| Academies and Institutes | 2 | 2019 | 81 | 0.230 |
Why?
|
| Adolescent | 27 | 2025 | 20982 | 0.230 |
Why?
|
| Substantia Nigra | 1 | 2025 | 35 | 0.230 |
Why?
|
| Rats | 7 | 2019 | 3460 | 0.230 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2009 | 47 | 0.220 |
Why?
|
| In Situ Hybridization | 7 | 2010 | 452 | 0.220 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 380 | 0.220 |
Why?
|
| Cerebellar Nuclei | 1 | 2024 | 12 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 1008 | 0.220 |
Why?
|
| Otx Transcription Factors | 1 | 2024 | 26 | 0.220 |
Why?
|
| Mosaicism | 7 | 2020 | 243 | 0.220 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2006 | 625 | 0.220 |
Why?
|
| Presynaptic Terminals | 2 | 2018 | 81 | 0.220 |
Why?
|
| Cricetinae | 15 | 2011 | 367 | 0.220 |
Why?
|
| Olfaction Disorders | 1 | 2024 | 28 | 0.220 |
Why?
|
| Research | 1 | 2006 | 268 | 0.220 |
Why?
|
| Stress, Physiological | 1 | 2006 | 262 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2019 | 636 | 0.210 |
Why?
|
| Enteric Nervous System | 1 | 2024 | 42 | 0.210 |
Why?
|
| Action Potentials | 4 | 2021 | 471 | 0.210 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2024 | 39 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2009 | 482 | 0.210 |
Why?
|
| Adult | 21 | 2025 | 31719 | 0.210 |
Why?
|
| Embryo, Mammalian | 6 | 2011 | 450 | 0.210 |
Why?
|
| Transglutaminases | 2 | 2022 | 27 | 0.200 |
Why?
|
| Cerebellar Ataxia | 3 | 2007 | 72 | 0.200 |
Why?
|
| Cell Survival | 4 | 2018 | 854 | 0.200 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 90 | 0.200 |
Why?
|
| PubMed | 1 | 2023 | 22 | 0.200 |
Why?
|
| Lithium | 2 | 2013 | 66 | 0.200 |
Why?
|
| Embryonic Development | 1 | 2005 | 225 | 0.200 |
Why?
|
| Spatial Learning | 2 | 2021 | 15 | 0.200 |
Why?
|
| Ligases | 2 | 2001 | 35 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2003 | 251 | 0.200 |
Why?
|
| Muscular Atrophy, Spinal | 3 | 2003 | 47 | 0.200 |
Why?
|
| Hair Cells, Auditory, Inner | 2 | 2003 | 19 | 0.200 |
Why?
|
| Multienzyme Complexes | 4 | 2004 | 77 | 0.200 |
Why?
|
| Stress, Psychological | 1 | 2008 | 562 | 0.200 |
Why?
|
| Recombination, Genetic | 4 | 2020 | 426 | 0.200 |
Why?
|
| Chromosomal Instability | 1 | 2003 | 60 | 0.200 |
Why?
|
| Olfactory Bulb | 1 | 2024 | 102 | 0.200 |
Why?
|
| LIM-Homeodomain Proteins | 4 | 2011 | 32 | 0.200 |
Why?
|
| Myotonic Dystrophy | 3 | 2005 | 123 | 0.200 |
Why?
|
| Growth Differentiation Factors | 1 | 2023 | 12 | 0.200 |
Why?
|
| Cysteine Endopeptidases | 4 | 2004 | 113 | 0.200 |
Why?
|
| Regulatory Factor X1 | 1 | 2022 | 6 | 0.200 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 18 | 0.200 |
Why?
|
| DNA, Complementary | 8 | 2001 | 436 | 0.190 |
Why?
|
| Evolution, Molecular | 4 | 2018 | 657 | 0.190 |
Why?
|
| Dendrites | 5 | 2013 | 182 | 0.190 |
Why?
|
| Diptera | 1 | 2002 | 20 | 0.190 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2013 | 30 | 0.190 |
Why?
|
| Immunoblotting | 3 | 2016 | 291 | 0.190 |
Why?
|
| Heterozygote | 5 | 2020 | 728 | 0.190 |
Why?
|
| Microtubule Proteins | 2 | 2001 | 28 | 0.190 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2023 | 126 | 0.180 |
Why?
|
| Infant | 15 | 2018 | 13306 | 0.180 |
Why?
|
| COS Cells | 10 | 2008 | 249 | 0.180 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2019 | 114 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2007 | 364 | 0.180 |
Why?
|
| Sequence Alignment | 6 | 2016 | 595 | 0.180 |
Why?
|
| Memory, Long-Term | 1 | 2022 | 35 | 0.180 |
Why?
|
| Models, Genetic | 6 | 2007 | 752 | 0.180 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2015 | 97 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 22 | 3 | 2013 | 102 | 0.180 |
Why?
|
| Symporters | 2 | 2000 | 74 | 0.180 |
Why?
|
| Genomic Imprinting | 3 | 2013 | 127 | 0.180 |
Why?
|
| Psychomotor Performance | 3 | 2021 | 178 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2018 | 144 | 0.170 |
Why?
|
| Zinc Fingers | 3 | 2014 | 119 | 0.170 |
Why?
|
| Machado-Joseph Disease | 4 | 2002 | 27 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 420 | 0.170 |
Why?
|
| Friedreich Ataxia | 4 | 2005 | 48 | 0.170 |
Why?
|
| Neuroglia | 2 | 2016 | 223 | 0.170 |
Why?
|
| Spermatozoa | 3 | 2020 | 258 | 0.170 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2019 | 83 | 0.170 |
Why?
|
| X Chromosome Inactivation | 3 | 2012 | 60 | 0.170 |
Why?
|
| DNA Primers | 11 | 2011 | 609 | 0.170 |
Why?
|
| Ubiquitin | 4 | 2006 | 133 | 0.170 |
Why?
|
| Family Health | 4 | 2014 | 251 | 0.170 |
Why?
|
| Age Factors | 6 | 2013 | 2872 | 0.170 |
Why?
|
| Gastrointestinal Diseases | 1 | 2024 | 341 | 0.170 |
Why?
|
| Cell Nucleolus | 1 | 2020 | 47 | 0.170 |
Why?
|
| Neurocognitive Disorders | 4 | 1989 | 75 | 0.170 |
Why?
|
| Lac Operon | 4 | 2005 | 89 | 0.160 |
Why?
|
| Helix-Loop-Helix Motifs | 4 | 2001 | 29 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2015 | 118 | 0.160 |
Why?
|
| Minisatellite Repeats | 3 | 2000 | 45 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 322 | 0.160 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.160 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2000 | 6 | 0.160 |
Why?
|
| Ear, Inner | 2 | 2003 | 42 | 0.160 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 20 | 0.160 |
Why?
|
| Pigmentation Disorders | 1 | 2000 | 23 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 1002 | 0.160 |
Why?
|
| Perirhinal Cortex | 1 | 2019 | 3 | 0.160 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 199 | 0.160 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2000 | 44 | 0.160 |
Why?
|
| Ammonia | 3 | 1989 | 70 | 0.160 |
Why?
|
| Peripheral Nervous System | 1 | 2000 | 46 | 0.160 |
Why?
|
| beta-Galactosidase | 4 | 2007 | 135 | 0.160 |
Why?
|
| Translocation, Genetic | 2 | 1993 | 350 | 0.160 |
Why?
|
| Genetic Association Studies | 3 | 2019 | 837 | 0.160 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2000 | 24 | 0.160 |
Why?
|
| Bone Diseases, Developmental | 1 | 2000 | 60 | 0.160 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 9 | 0.150 |
Why?
|
| Protein Phosphatase 2 | 2 | 2017 | 33 | 0.150 |
Why?
|
| Cholinergic Neurons | 1 | 2019 | 28 | 0.150 |
Why?
|
| Models, Neurological | 1 | 2021 | 197 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 7 | 2017 | 1745 | 0.150 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 33 | 0.150 |
Why?
|
| DNA Probes | 7 | 1993 | 120 | 0.150 |
Why?
|
| Uncertainty | 1 | 2020 | 96 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 600 | 0.150 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 17 | 0.150 |
Why?
|
| Membrane Potentials | 3 | 2017 | 297 | 0.150 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 59 | 0.150 |
Why?
|
| Lysosomes | 1 | 2021 | 260 | 0.150 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2012 | 82 | 0.150 |
Why?
|
| Immunoprecipitation | 4 | 2015 | 191 | 0.150 |
Why?
|
| Cell Death | 2 | 2015 | 237 | 0.150 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 11 | 0.150 |
Why?
|
| Genes, Essential | 1 | 1999 | 43 | 0.150 |
Why?
|
| HeLa Cells | 6 | 2011 | 694 | 0.150 |
Why?
|
| Stereotyped Behavior | 3 | 2015 | 35 | 0.150 |
Why?
|
| Embryonic and Fetal Development | 4 | 2003 | 126 | 0.150 |
Why?
|
| RNA | 5 | 2005 | 531 | 0.150 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 136 | 0.150 |
Why?
|
| Precision Medicine | 1 | 2022 | 376 | 0.140 |
Why?
|
| Gene Rearrangement | 2 | 2011 | 323 | 0.140 |
Why?
|
| Base Pairing | 1 | 2018 | 41 | 0.140 |
Why?
|
| Receptors, Glycine | 1 | 1998 | 16 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2005 | 242 | 0.140 |
Why?
|
| Software | 3 | 2020 | 752 | 0.140 |
Why?
|
| Spliceosomes | 1 | 2018 | 46 | 0.140 |
Why?
|
| Spatial Memory | 1 | 2018 | 29 | 0.140 |
Why?
|
| Models, Molecular | 3 | 2016 | 1087 | 0.140 |
Why?
|
| Amyloidosis | 1 | 2019 | 71 | 0.140 |
Why?
|
| Introns | 7 | 2010 | 287 | 0.140 |
Why?
|
| Nuclear Localization Signals | 3 | 2015 | 16 | 0.140 |
Why?
|
| Disease Progression | 7 | 2019 | 2206 | 0.140 |
Why?
|
| Prosencephalon | 1 | 2018 | 41 | 0.140 |
Why?
|
| Hypoglossal Nerve | 1 | 2018 | 11 | 0.140 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2018 | 11 | 0.140 |
Why?
|
| Trans-Activators | 4 | 2011 | 692 | 0.140 |
Why?
|
| Motor Cortex | 1 | 2018 | 63 | 0.140 |
Why?
|
| Caffeine | 1 | 2018 | 67 | 0.140 |
Why?
|
| Gliosis | 1 | 2018 | 34 | 0.140 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 97 | 0.140 |
Why?
|
| Biogenic Amines | 3 | 1989 | 17 | 0.140 |
Why?
|
| Oocytes | 1 | 2020 | 283 | 0.140 |
Why?
|
| Gene Library | 6 | 2003 | 213 | 0.140 |
Why?
|
| Meningioma | 1 | 2019 | 135 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 75 | 0.130 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 236 | 0.130 |
Why?
|
| Protein Aggregates | 1 | 2018 | 43 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 159 | 0.130 |
Why?
|
| Amino Acid Substitution | 4 | 2015 | 410 | 0.130 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 96 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2018 | 108 | 0.130 |
Why?
|
| Ubiquitins | 4 | 2001 | 39 | 0.130 |
Why?
|
| Protein Conformation | 4 | 2006 | 810 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 279 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 114 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 739 | 0.130 |
Why?
|
| Pars Compacta | 1 | 2017 | 5 | 0.130 |
Why?
|
| Muscular Disorders, Atrophic | 3 | 2003 | 3 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 1995 | 91 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 206 | 0.130 |
Why?
|
| Chimera | 2 | 2002 | 79 | 0.130 |
Why?
|
| Antigens, Ly | 2 | 2015 | 33 | 0.130 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 161 | 0.130 |
Why?
|
| History, 21st Century | 2 | 2019 | 263 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 48 | 0.130 |
Why?
|
| Diaphragm | 1 | 2018 | 102 | 0.130 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1996 | 21 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 305 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 765 | 0.130 |
Why?
|
| Reflex, Startle | 3 | 2012 | 34 | 0.130 |
Why?
|
| Neural Pathways | 3 | 2010 | 285 | 0.120 |
Why?
|
| Liver | 2 | 2015 | 1799 | 0.120 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 38 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 195 | 0.120 |
Why?
|
| Species Specificity | 5 | 2018 | 519 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2019 | 493 | 0.120 |
Why?
|
| Chromosomes, Fungal | 3 | 1993 | 49 | 0.120 |
Why?
|
| DNA, Recombinant | 2 | 1996 | 71 | 0.120 |
Why?
|
| Tissue Distribution | 4 | 2002 | 366 | 0.120 |
Why?
|
| Actins | 2 | 2013 | 317 | 0.120 |
Why?
|
| Skin Diseases | 1 | 1997 | 141 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 7 | 2016 | 1218 | 0.120 |
Why?
|
| Protein Transport | 4 | 2022 | 362 | 0.120 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 421 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2016 | 2463 | 0.120 |
Why?
|
| Maze Learning | 3 | 2007 | 99 | 0.120 |
Why?
|
| Chromosome Deletion | 4 | 2018 | 650 | 0.120 |
Why?
|
| Pancreas | 1 | 2016 | 218 | 0.120 |
Why?
|
| Sensation | 1 | 2015 | 49 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 1996 | 121 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 566 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 665 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 136 | 0.110 |
Why?
|
| Biological Evolution | 1 | 1996 | 229 | 0.110 |
Why?
|
| Microscopy, Confocal | 3 | 2004 | 363 | 0.110 |
Why?
|
| Photoreceptor Cells | 2 | 2006 | 91 | 0.110 |
Why?
|
| Genetic Engineering | 2 | 2008 | 163 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2012 | 8589 | 0.110 |
Why?
|
| Exploratory Behavior | 2 | 2013 | 53 | 0.110 |
Why?
|
| France | 1 | 2014 | 89 | 0.110 |
Why?
|
| Retinal Degeneration | 2 | 2011 | 98 | 0.110 |
Why?
|
| Albinism, Ocular | 2 | 1994 | 20 | 0.110 |
Why?
|
| Nerve Fibers | 2 | 2013 | 69 | 0.110 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2014 | 22 | 0.110 |
Why?
|
| Lip | 1 | 2014 | 23 | 0.100 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2014 | 11 | 0.100 |
Why?
|
| Cochlea | 3 | 2005 | 88 | 0.100 |
Why?
|
| Epilepsy | 5 | 2020 | 889 | 0.100 |
Why?
|
| Cytoskeleton | 2 | 2008 | 167 | 0.100 |
Why?
|
| United States | 8 | 2025 | 11804 | 0.100 |
Why?
|
| Tropomodulin | 3 | 2003 | 4 | 0.100 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 11 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2011 | 2862 | 0.100 |
Why?
|
| Pregnancy | 3 | 2012 | 7572 | 0.100 |
Why?
|
| Genes, Lethal | 4 | 2020 | 75 | 0.100 |
Why?
|
| Huntingtin Protein | 2 | 2006 | 63 | 0.100 |
Why?
|
| Optic Atrophy | 1 | 2014 | 46 | 0.100 |
Why?
|
| Yeasts | 2 | 1997 | 42 | 0.100 |
Why?
|
| Protein Interaction Mapping | 2 | 2011 | 91 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2005 | 255 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1686 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 744 | 0.100 |
Why?
|
| X-linked Nuclear Protein | 1 | 2013 | 14 | 0.100 |
Why?
|
| Heterochromatin | 1 | 2013 | 45 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2014 | 418 | 0.100 |
Why?
|
| Hydroxyindoleacetic Acid | 3 | 2009 | 28 | 0.100 |
Why?
|
| Homovanillic Acid | 3 | 2009 | 30 | 0.100 |
Why?
|
| Goblet Cells | 2 | 2005 | 104 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1277 | 0.100 |
Why?
|
| Valproic Acid | 1 | 2013 | 161 | 0.100 |
Why?
|
| S100 Calcium Binding Protein G | 4 | 2013 | 21 | 0.100 |
Why?
|
| Histone Acetyltransferases | 2 | 2011 | 224 | 0.100 |
Why?
|
| Restriction Mapping | 5 | 1996 | 171 | 0.100 |
Why?
|
| Dinucleoside Phosphates | 2 | 1992 | 12 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 607 | 0.090 |
Why?
|
| Solubility | 2 | 2003 | 118 | 0.090 |
Why?
|
| Skin | 2 | 2009 | 553 | 0.090 |
Why?
|
| Bile Acids and Salts | 1 | 2015 | 257 | 0.090 |
Why?
|
| Intestine, Small | 2 | 2007 | 287 | 0.090 |
Why?
|
| Repetitive Sequences, Amino Acid | 3 | 2004 | 18 | 0.090 |
Why?
|
| Blotting, Southern | 10 | 2002 | 208 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2013 | 93 | 0.090 |
Why?
|
| Survival Rate | 3 | 2020 | 2151 | 0.090 |
Why?
|
| Methylmalonyl-CoA Mutase | 2 | 1988 | 4 | 0.090 |
Why?
|
| Lymphocytes | 4 | 2015 | 359 | 0.090 |
Why?
|
| Isomerases | 2 | 1988 | 22 | 0.090 |
Why?
|
| Factor VIIIa | 1 | 1991 | 1 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 934 | 0.090 |
Why?
|
| Proteome | 3 | 2017 | 286 | 0.090 |
Why?
|
| Dimerization | 2 | 2013 | 139 | 0.090 |
Why?
|
| Body Weight | 3 | 2020 | 990 | 0.090 |
Why?
|
| Th1 Cells | 1 | 2012 | 156 | 0.090 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 3 | 2021 | 21 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 1 | 1991 | 55 | 0.090 |
Why?
|
| Gene Frequency | 4 | 2019 | 750 | 0.090 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 45 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2013 | 230 | 0.090 |
Why?
|
| HLA-A Antigens | 1 | 1991 | 33 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 237 | 0.090 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 57 | 0.090 |
Why?
|
| Crosses, Genetic | 3 | 2008 | 155 | 0.090 |
Why?
|
| Organogenesis | 1 | 2011 | 82 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 329 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 139 | 0.090 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2010 | 17 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 145 | 0.080 |
Why?
|
| Depression | 1 | 2020 | 1350 | 0.080 |
Why?
|
| Psychomotor Disorders | 1 | 2010 | 30 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 43 | 0.080 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 7 | 0.080 |
Why?
|
| Metabolome | 1 | 2013 | 329 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 387 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2010 | 15 | 0.080 |
Why?
|
| Compulsive Behavior | 1 | 2010 | 46 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2011 | 86 | 0.080 |
Why?
|
| Models, Animal | 2 | 2010 | 460 | 0.080 |
Why?
|
| Open Reading Frames | 2 | 2008 | 200 | 0.080 |
Why?
|
| Aspartic Acid | 1 | 2010 | 83 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 997 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 1991 | 132 | 0.080 |
Why?
|
| Precipitin Tests | 3 | 2007 | 137 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6925 | 0.080 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Risk Factors | 2 | 2025 | 10959 | 0.080 |
Why?
|
| Smoothened Receptor | 1 | 2009 | 31 | 0.080 |
Why?
|
| Receptors, Glutamate | 2 | 2000 | 18 | 0.080 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 21 | 0.080 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2010 | 67 | 0.080 |
Why?
|
| Chromosome Aberrations | 3 | 2006 | 577 | 0.080 |
Why?
|
| Auditory Pathways | 1 | 2009 | 20 | 0.080 |
Why?
|
| Medical Records | 1 | 2010 | 181 | 0.080 |
Why?
|
| Amines | 1 | 2009 | 37 | 0.080 |
Why?
|
| Mice, Congenic | 1 | 2009 | 17 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 379 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 3 | 2005 | 312 | 0.080 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 297 | 0.080 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 21 | 0.080 |
Why?
|
| Auditory Perception | 1 | 2009 | 41 | 0.080 |
Why?
|
| Cochlear Nucleus | 1 | 2009 | 10 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2009 | 82 | 0.080 |
Why?
|
| Luminescent Proteins | 2 | 2015 | 157 | 0.080 |
Why?
|
| Levodopa | 1 | 2009 | 92 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2010 | 91 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 5 | 1992 | 48 | 0.080 |
Why?
|
| Acoustic Stimulation | 1 | 2009 | 84 | 0.080 |
Why?
|
| Fetus | 1 | 2013 | 585 | 0.080 |
Why?
|
| Phosphoserine | 1 | 2009 | 38 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 1492 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 112 | 0.070 |
Why?
|
| Foot | 1 | 2009 | 62 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 551 | 0.070 |
Why?
|
| Sex Characteristics | 2 | 2009 | 338 | 0.070 |
Why?
|
| Factor XIII | 1 | 1988 | 7 | 0.070 |
Why?
|
| Blotting, Northern | 4 | 2001 | 236 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 160 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 80 | 0.070 |
Why?
|
| Cognition Disorders | 3 | 2020 | 565 | 0.070 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2008 | 8 | 0.070 |
Why?
|
| Molecular Biology | 2 | 2001 | 68 | 0.070 |
Why?
|
| Phenylalanine | 1 | 2008 | 126 | 0.070 |
Why?
|
| Gene Ontology | 2 | 2020 | 53 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 98 | 0.070 |
Why?
|
| Nuclear Matrix | 2 | 1997 | 17 | 0.070 |
Why?
|
| Transcription Factor 4 | 1 | 2007 | 12 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2024 | 769 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2008 | 137 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 164 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 2005 | 114 | 0.070 |
Why?
|
| Cosmids | 2 | 1997 | 40 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 300 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2007 | 59 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2005 | 404 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 60 | 0.060 |
Why?
|
| Adiposity | 1 | 2008 | 207 | 0.060 |
Why?
|
| Homozygote | 2 | 2020 | 547 | 0.060 |
Why?
|
| Middle Aged | 7 | 2019 | 28889 | 0.060 |
Why?
|
| Dementia | 3 | 1987 | 434 | 0.060 |
Why?
|
| Wings, Animal | 1 | 2006 | 30 | 0.060 |
Why?
|
| CHO Cells | 4 | 2011 | 149 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2006 | 4 | 0.060 |
Why?
|
| Oxo-Acid-Lyases | 1 | 1986 | 5 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2009 | 466 | 0.060 |
Why?
|
| Nerve Net | 1 | 2009 | 268 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 414 | 0.060 |
Why?
|
| Ileum | 1 | 2007 | 124 | 0.060 |
Why?
|
| Aggression | 1 | 2008 | 221 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 195 | 0.060 |
Why?
|
| Tyrosine | 1 | 2006 | 148 | 0.060 |
Why?
|
| Sex Chromosome Aberrations | 3 | 1994 | 62 | 0.060 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2006 | 89 | 0.060 |
Why?
|
| Cricetulus | 4 | 2011 | 88 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 3101 | 0.060 |
Why?
|
| Eye Abnormalities | 1 | 2006 | 107 | 0.060 |
Why?
|
| Organ Size | 1 | 2007 | 435 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2006 | 161 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 160 | 0.060 |
Why?
|
| Zebrafish | 1 | 2008 | 428 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 1986 | 99 | 0.060 |
Why?
|
| Peyer's Patches | 1 | 2005 | 17 | 0.060 |
Why?
|
| Glycoside Hydrolases | 1 | 2005 | 17 | 0.060 |
Why?
|
| Ear | 1 | 2005 | 27 | 0.060 |
Why?
|
| Receptors, Notch | 3 | 2003 | 204 | 0.060 |
Why?
|
| Lung | 2 | 2005 | 1565 | 0.060 |
Why?
|
| Plasmids | 3 | 2005 | 455 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2007 | 198 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 1306 | 0.060 |
Why?
|
| Calbindins | 3 | 2013 | 17 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2007 | 694 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 437 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 261 | 0.060 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2005 | 20 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2019 | 832 | 0.060 |
Why?
|
| Mitochondria | 1 | 2010 | 759 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2005 | 116 | 0.050 |
Why?
|
| Genetic Variation | 6 | 2021 | 1556 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2006 | 155 | 0.050 |
Why?
|
| Chromatography, Gel | 2 | 2015 | 78 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2015 | 955 | 0.050 |
Why?
|
| Young Adult | 4 | 2025 | 10104 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2020 | 5123 | 0.050 |
Why?
|
| Brain Chemistry | 3 | 1995 | 111 | 0.050 |
Why?
|
| Fetal Viability | 1 | 2004 | 29 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 134 | 0.050 |
Why?
|
| Neuregulins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Neutropenia | 1 | 2005 | 205 | 0.050 |
Why?
|
| Myofibrils | 1 | 2003 | 24 | 0.050 |
Why?
|
| Embryo Loss | 1 | 2003 | 25 | 0.050 |
Why?
|
| Mexican Americans | 2 | 2002 | 166 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2005 | 220 | 0.050 |
Why?
|
| Multigene Family | 4 | 1994 | 290 | 0.050 |
Why?
|
| Pediatrics | 1 | 2013 | 1231 | 0.050 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2003 | 26 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2001 | 60 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 3 | 2013 | 279 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 989 | 0.050 |
Why?
|
| Deoxyribonuclease HpaII | 3 | 1992 | 8 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 232 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1996 | 299 | 0.050 |
Why?
|
| DiGeorge Syndrome | 1 | 2003 | 81 | 0.050 |
Why?
|
| Muscle Spasticity | 1 | 2003 | 56 | 0.050 |
Why?
|
| Germ Cells | 2 | 2020 | 202 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2008 | 724 | 0.050 |
Why?
|
| Microtubules | 1 | 2003 | 128 | 0.050 |
Why?
|
| Electric Stimulation | 3 | 2013 | 249 | 0.050 |
Why?
|
| Angelman Syndrome | 1 | 2003 | 68 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 75 | 0.050 |
Why?
|
| Amino Acids | 2 | 2002 | 620 | 0.050 |
Why?
|
| Leadership | 1 | 2025 | 242 | 0.050 |
Why?
|
| SUMO-1 Protein | 1 | 2002 | 8 | 0.050 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2003 | 76 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2003 | 201 | 0.050 |
Why?
|
| Hair | 1 | 2002 | 32 | 0.050 |
Why?
|
| Ear, Middle | 1 | 2002 | 24 | 0.050 |
Why?
|
| Genes, Insect | 1 | 2002 | 113 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2002 | 110 | 0.050 |
Why?
|
| Transcription Factor HES-1 | 1 | 2001 | 17 | 0.050 |
Why?
|
| Receptors, GABA | 2 | 2000 | 16 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 316 | 0.050 |
Why?
|
| Hemochromatosis | 2 | 1992 | 39 | 0.050 |
Why?
|
| Intestine, Large | 1 | 2001 | 12 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2003 | 89 | 0.050 |
Why?
|
| Centromere | 3 | 2005 | 69 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2001 | 18 | 0.050 |
Why?
|
| Paneth Cells | 1 | 2001 | 23 | 0.050 |
Why?
|
| Cerebellar Cortex | 2 | 2007 | 20 | 0.050 |
Why?
|
| Vesicular Glutamate Transport Protein 1 | 1 | 2021 | 14 | 0.040 |
Why?
|
| Fetal Death | 1 | 2002 | 119 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2001 | 104 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 122 | 0.040 |
Why?
|
| Vocalization, Animal | 1 | 2021 | 21 | 0.040 |
Why?
|
| Polydactyly | 1 | 2001 | 18 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2003 | 238 | 0.040 |
Why?
|
| Phylogeny | 1 | 2004 | 709 | 0.040 |
Why?
|
| Gene Order | 1 | 2001 | 82 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 156 | 0.040 |
Why?
|
| Receptors, Androgen | 2 | 1996 | 419 | 0.040 |
Why?
|
| Enterocytes | 1 | 2001 | 68 | 0.040 |
Why?
|
| Spasms, Infantile | 1 | 2003 | 165 | 0.040 |
Why?
|
| Dystonia | 1 | 2003 | 174 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2002 | 132 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 344 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 163 | 0.040 |
Why?
|
| Hyperargininemia | 1 | 2001 | 13 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2001 | 147 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 169 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 256 | 0.040 |
Why?
|
| Arginase | 1 | 2001 | 36 | 0.040 |
Why?
|
| Body Patterning | 1 | 2001 | 128 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2002 | 234 | 0.040 |
Why?
|
| Genetics | 1 | 2000 | 24 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2021 | 152 | 0.040 |
Why?
|
| Postural Balance | 1 | 2001 | 130 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 1999 | 314 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2018 | 1521 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 365 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 249 | 0.040 |
Why?
|
| alpha 1-Antichymotrypsin | 1 | 2000 | 4 | 0.040 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2000 | 4 | 0.040 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2000 | 6 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2002 | 221 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2000 | 32 | 0.040 |
Why?
|
| Lod Score | 1 | 2000 | 128 | 0.040 |
Why?
|
| Sequence Tagged Sites | 3 | 1995 | 27 | 0.040 |
Why?
|
| Proton-Translocating ATPases | 1 | 2000 | 18 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2000 | 37 | 0.040 |
Why?
|
| TRPC Cation Channels | 1 | 2000 | 20 | 0.040 |
Why?
|
| Neurites | 1 | 2000 | 45 | 0.040 |
Why?
|
| Haplotypes | 2 | 2000 | 543 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2003 | 901 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 208 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2000 | 34 | 0.040 |
Why?
|
| Hindlimb | 1 | 2020 | 73 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 2000 | 44 | 0.040 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 2 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12984 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2000 | 64 | 0.040 |
Why?
|
| Calbindin 2 | 1 | 1999 | 15 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 231 | 0.040 |
Why?
|
| Saccule and Utricle | 1 | 1999 | 9 | 0.040 |
Why?
|
| Leukocytes | 2 | 2004 | 211 | 0.040 |
Why?
|
| Lymphoma | 1 | 2003 | 330 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 110 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 99 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2000 | 147 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 96 | 0.040 |
Why?
|
| Diseases in Twins | 2 | 1991 | 90 | 0.040 |
Why?
|
| Mice, Inbred C3H | 2 | 2016 | 108 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 2 | 2011 | 17 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2003 | 3917 | 0.040 |
Why?
|
| Optogenetics | 1 | 2019 | 77 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 1999 | 74 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 68 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 675 | 0.040 |
Why?
|
| RNA, Nuclear | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 88 | 0.040 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 1998 | 4 | 0.040 |
Why?
|
| DNA Repair | 2 | 2009 | 562 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 1998 | 55 | 0.040 |
Why?
|
| Topotecan | 1 | 2018 | 48 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 45 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2023 | 1224 | 0.040 |
Why?
|
| Focal Dermal Hypoplasia | 1 | 1998 | 17 | 0.040 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1998 | 21 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2018 | 37 | 0.040 |
Why?
|
| Epithelium | 1 | 1999 | 343 | 0.040 |
Why?
|
| Anemia | 1 | 2002 | 355 | 0.040 |
Why?
|
| Sumoylation | 1 | 2018 | 41 | 0.030 |
Why?
|
| src Homology Domains | 1 | 1997 | 35 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 153 | 0.030 |
Why?
|
| Bias | 1 | 2018 | 144 | 0.030 |
Why?
|
| Synucleins | 1 | 1997 | 13 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3454 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2143 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 283 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1997 | 99 | 0.030 |
Why?
|
| Maternal Age | 1 | 1997 | 137 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1454 | 0.030 |
Why?
|
| Endocrine System | 1 | 2016 | 18 | 0.030 |
Why?
|
| Oxadiazoles | 1 | 2016 | 25 | 0.030 |
Why?
|
| Genomics | 1 | 2005 | 1625 | 0.030 |
Why?
|
| Neurospora crassa | 1 | 1996 | 5 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 229 | 0.030 |
Why?
|
| Monosomy | 1 | 1996 | 25 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1996 | 93 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 50 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cholecystokinin | 1 | 2016 | 12 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 2016 | 26 | 0.030 |
Why?
|
| Imaginal Discs | 1 | 2016 | 10 | 0.030 |
Why?
|
| Texas | 2 | 2002 | 3622 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 703 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 1996 | 23 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2000 | 781 | 0.030 |
Why?
|
| Aged | 3 | 2025 | 21261 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2018 | 500 | 0.030 |
Why?
|
| Nucleotides | 1 | 1995 | 90 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 51 | 0.030 |
Why?
|
| Pseudogenes | 2 | 1993 | 50 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 136 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2015 | 36 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 1997 | 515 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 227 | 0.030 |
Why?
|
| Fluorescent Dyes | 2 | 2013 | 251 | 0.030 |
Why?
|
| Iron | 1 | 2018 | 310 | 0.030 |
Why?
|
| Testis | 2 | 2005 | 413 | 0.030 |
Why?
|
| Hominidae | 1 | 1995 | 25 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 66 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1995 | 59 | 0.030 |
Why?
|
| HLA-B Antigens | 2 | 1991 | 30 | 0.030 |
Why?
|
| RNA Stability | 1 | 2015 | 75 | 0.030 |
Why?
|
| Chromosome Walking | 1 | 1994 | 8 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 389 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 83 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 180 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1995 | 101 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 1996 | 251 | 0.030 |
Why?
|
| Eye | 1 | 2016 | 227 | 0.030 |
Why?
|
| Naltrexone | 1 | 1994 | 70 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6494 | 0.030 |
Why?
|
| Chloride Channels | 1 | 1994 | 60 | 0.030 |
Why?
|
| High Mobility Group Proteins | 1 | 1993 | 32 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1993 | 55 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 1992 | 136 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 226 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1993 | 54 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 66 | 0.030 |
Why?
|
| Somatosensory Cortex | 1 | 2013 | 56 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 792 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2014 | 364 | 0.020 |
Why?
|
| Muscle Hypotonia | 1 | 2014 | 194 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2004 | 48 | 0.020 |
Why?
|
| Leishmania major | 1 | 2012 | 27 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 12 | 0.020 |
Why?
|
| Organ of Corti | 2 | 2003 | 27 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2013 | 97 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 300 | 0.020 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2012 | 49 | 0.020 |
Why?
|
| Optical Imaging | 1 | 2013 | 76 | 0.020 |
Why?
|
| Receptors, GABA-B | 1 | 1992 | 11 | 0.020 |
Why?
|
| Research Report | 1 | 2012 | 71 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2013 | 197 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1992 | 109 | 0.020 |
Why?
|
| Kidney | 2 | 2001 | 1309 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2012 | 63 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 1992 | 60 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1991 | 34 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1992 | 148 | 0.020 |
Why?
|
| DNA, Satellite | 1 | 1991 | 15 | 0.020 |
Why?
|
| Splicing Factor U2AF | 1 | 2011 | 9 | 0.020 |
Why?
|
| Electroporation | 1 | 2011 | 37 | 0.020 |
Why?
|
| Muscles | 2 | 1991 | 222 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1995 | 464 | 0.020 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 56 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 1991 | 71 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 187 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 200 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 114 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 1991 | 52 | 0.020 |
Why?
|
| Ferritins | 1 | 1991 | 109 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2011 | 28 | 0.020 |
Why?
|
| Gamma Rays | 1 | 1991 | 43 | 0.020 |
Why?
|
| Microcephaly | 1 | 2014 | 354 | 0.020 |
Why?
|
| Telomere | 1 | 1992 | 220 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 1991 | 125 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1991 | 227 | 0.020 |
Why?
|
| Prevalence | 1 | 1997 | 2694 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 1010 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 542 | 0.020 |
Why?
|
| Ataxin-10 | 1 | 2010 | 28 | 0.020 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1990 | 5 | 0.020 |
Why?
|
| Cell Count | 2 | 2002 | 217 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 845 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4952 | 0.020 |
Why?
|
| Weight Gain | 1 | 2012 | 384 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2009 | 32 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2009 | 16 | 0.020 |
Why?
|
| Metabolomics | 1 | 2013 | 493 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 12 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2009 | 58 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 54 | 0.020 |
Why?
|
| DNA Probes, HLA | 1 | 1989 | 2 | 0.020 |
Why?
|
| Dihydropteridine Reductase | 1 | 1989 | 4 | 0.020 |
Why?
|
| Neopterin | 1 | 1989 | 4 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 25 | 0.020 |
Why?
|
| Motor Skills | 2 | 1988 | 75 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 1985 | 34 | 0.020 |
Why?
|
| Sural Nerve | 2 | 1985 | 46 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 1348 | 0.020 |
Why?
|
| Alanine | 1 | 2009 | 163 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 124 | 0.020 |
Why?
|
| Nesting Behavior | 1 | 2008 | 10 | 0.020 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2007 | 16 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 18 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1988 | 88 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 27 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2007 | 38 | 0.020 |
Why?
|
| Amygdala | 1 | 2008 | 86 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2007 | 97 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 127 | 0.020 |
Why?
|
| Medicare | 1 | 2010 | 437 | 0.020 |
Why?
|
| Sleep | 2 | 1987 | 373 | 0.020 |
Why?
|
| Muscle Proteins | 2 | 2003 | 404 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 138 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1842 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2006 | 21 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2006 | 63 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 58 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 1600 | 0.010 |
Why?
|
| Octoxynol | 1 | 2005 | 7 | 0.010 |
Why?
|
| Detergents | 1 | 2005 | 21 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2000 | 274 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2005 | 51 | 0.010 |
Why?
|
| Reaction Time | 2 | 2001 | 157 | 0.010 |
Why?
|
| Pain | 1 | 2008 | 439 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 53 | 0.010 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 51 | 0.010 |
Why?
|
| Blood Viscosity | 1 | 1974 | 9 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 2005 | 52 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2004 | 40 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2005 | 92 | 0.010 |
Why?
|
| Rheology | 1 | 1974 | 25 | 0.010 |
Why?
|
| Homer Scaffolding Proteins | 1 | 2004 | 3 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 66 | 0.010 |
Why?
|
| Autoantigens | 1 | 2005 | 104 | 0.010 |
Why?
|
| Myocardium | 2 | 2003 | 874 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 175 | 0.010 |
Why?
|
| Biological Assay | 1 | 2005 | 108 | 0.010 |
Why?
|
| Rabbits | 2 | 1997 | 633 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 112 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2005 | 119 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 48 | 0.010 |
Why?
|
| Actinin | 1 | 2003 | 7 | 0.010 |
Why?
|
| Doxycycline | 1 | 2004 | 115 | 0.010 |
Why?
|
| Connectin | 1 | 2003 | 28 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 226 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 2003 | 49 | 0.010 |
Why?
|
| Rodentia | 2 | 1993 | 50 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1994 | 92 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 59 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 77 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 122 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 75 | 0.010 |
Why?
|
| Totipotent Stem Cells | 1 | 2002 | 2 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 429 | 0.010 |
Why?
|
| Holoenzymes | 1 | 2002 | 14 | 0.010 |
Why?
|
| Inferior Colliculi | 1 | 2002 | 4 | 0.010 |
Why?
|
| Blastocyst | 1 | 2002 | 78 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 145 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 56 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2002 | 18 | 0.010 |
Why?
|
| Dyneins | 1 | 2002 | 12 | 0.010 |
Why?
|
| Choristoma | 1 | 2002 | 47 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 248 | 0.010 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2002 | 13 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 489 | 0.010 |
Why?
|
| Myosins | 1 | 2002 | 42 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 405 | 0.010 |
Why?
|
| Spain | 1 | 2002 | 62 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1986 | 864 | 0.010 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2001 | 8 | 0.010 |
Why?
|
| Calcium Channels, P-Type | 1 | 2001 | 9 | 0.010 |
Why?
|
| Conditioning, Classical | 1 | 2002 | 53 | 0.010 |
Why?
|
| Italy | 1 | 2002 | 133 | 0.010 |
Why?
|
| Ion Transport | 1 | 2001 | 48 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 158 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2007 | 557 | 0.010 |
Why?
|
| Mexico | 1 | 2002 | 198 | 0.010 |
Why?
|
| Canada | 1 | 2002 | 327 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2001 | 148 | 0.010 |
Why?
|
| Cell Size | 1 | 2001 | 79 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 216 | 0.010 |
Why?
|
| Polyamines | 1 | 2001 | 37 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 677 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2001 | 72 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2000 | 88 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2000 | 34 | 0.010 |
Why?
|
| Autophagy-Related Proteins | 1 | 2000 | 37 | 0.010 |
Why?
|
| Ganglia, Invertebrate | 1 | 2000 | 5 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 432 | 0.010 |
Why?
|
| Pupa | 1 | 2000 | 21 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 55 | 0.010 |
Why?
|
| Incontinentia Pigmenti | 1 | 1999 | 16 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1999 | 27 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1999 | 49 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2000 | 334 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 692 | 0.010 |
Why?
|
| Gestational Age | 1 | 2003 | 1221 | 0.010 |
Why?
|
| Visual Pathways | 1 | 2000 | 80 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2001 | 464 | 0.010 |
Why?
|
| Larva | 1 | 2000 | 252 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 3834 | 0.010 |
Why?
|
| Paris | 1 | 1998 | 11 | 0.010 |
Why?
|
| Rotation | 1 | 1998 | 40 | 0.010 |
Why?
|
| Arginine | 1 | 2001 | 344 | 0.010 |
Why?
|
| Japan | 1 | 1998 | 173 | 0.010 |
Why?
|
| Breeding | 1 | 1997 | 19 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 580 | 0.010 |
Why?
|
| Cytosine | 1 | 1997 | 53 | 0.010 |
Why?
|
| Guanine | 1 | 1997 | 65 | 0.010 |
Why?
|
| Oogenesis | 1 | 1997 | 52 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 29 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 1999 | 373 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1626 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 318 | 0.010 |
Why?
|
| Axons | 1 | 2000 | 385 | 0.010 |
Why?
|
| Adenine | 1 | 1997 | 124 | 0.010 |
Why?
|
| Wakefulness | 2 | 1987 | 103 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1996 | 27 | 0.010 |
Why?
|
| Intervertebral Disc | 1 | 1996 | 13 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2000 | 653 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 17667 | 0.010 |
Why?
|
| Mesoderm | 1 | 1996 | 108 | 0.010 |
Why?
|
| Color Vision Defects | 1 | 1995 | 4 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 141 | 0.010 |
Why?
|
| Torpedo | 1 | 1994 | 34 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1994 | 108 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 1993 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 1993 | 5 | 0.010 |
Why?
|
| Y Chromosome | 1 | 1994 | 47 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 1993 | 6 | 0.010 |
Why?
|
| Information Systems | 1 | 1994 | 29 | 0.010 |
Why?
|
| HMGA1a Protein | 1 | 1993 | 4 | 0.010 |
Why?
|
| Child Development | 2 | 1988 | 272 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 1993 | 13 | 0.010 |
Why?
|
| Disorders of Sex Development | 1 | 1994 | 71 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 1021 | 0.010 |
Why?
|
| Muridae | 1 | 1992 | 15 | 0.010 |
Why?
|
| Thymine Nucleotides | 1 | 1991 | 3 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 755 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1991 | 13 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1991 | 37 | 0.010 |
Why?
|
| Densitometry | 1 | 1991 | 16 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1988 | 1911 | 0.010 |
Why?
|
| Karyotyping | 1 | 1992 | 314 | 0.010 |
Why?
|
| Dystrophin | 1 | 1991 | 41 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1994 | 1636 | 0.000 |
Why?
|
| t-Complex Genome Region | 1 | 1989 | 1 | 0.000 |
Why?
|
| Chromosome Inversion | 1 | 1989 | 73 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1988 | 5 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 73 | 0.000 |
Why?
|
| Endorphins | 1 | 1988 | 6 | 0.000 |
Why?
|
| Enkephalins | 1 | 1988 | 18 | 0.000 |
Why?
|
| Atrophy | 1 | 1988 | 251 | 0.000 |
Why?
|
| Sleep, REM | 1 | 1987 | 17 | 0.000 |
Why?
|
| Transistors, Electronic | 1 | 1974 | 2 | 0.000 |
Why?
|
| Biopsy | 1 | 1985 | 1252 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1987 | 2120 | 0.000 |
Why?
|